IP Library Granted Patent US 10,155,819
Granted Patent B2
US 10,155,819 · App. 14/165,896 · Granted Dec 18, 2018

Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy

Inventors: James M Cregg (Claremont, CA); John Latham (Seattle, WA); Mark Litton (Seattle, WA); Randal Schatzman (Redmond, WA); Ilya Tolstrorukov (Claremont, CA)
Assignees: ALDERBIO HOLDINGS LLC; KECK GRADUATE INSTITUTE
C07K16/2896C07K16/00C07K16/18C07K16/2809C12N15/81C12N15/815C07K2317/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,155,819
App. No.
14/165,896
Granted
Dec 18, 2018
Kind
B2
Abstract

Methods are provided for the synthesis and secretion of recombinant hetero-multimeric proteins in mating competent yeast. A first expression vector is transformed into a first haploid cell; and a second expression vector is transformed into a second haploid cell. The transformed haploid cells, each individually synthesizing a non-identical polypeptide, are identified and then genetically crossed or fused. The resulting diploid strains are utilized to produce and secrete fully assembled and biologically functional hetero-multimeric protein.

Claims (26)

1. A method for producing a diploid Pichia yeast strain capable of expression and secretion of a desired heterologous heteromultimeric protein into a culture medium containing said diploid Pichia yeast strain; wherein said heteromultimeric protein comprises at least two non-identical subunit polypeptide chains, the method comprising:

(i) obtaining a first haploid Pichia yeast strain which comprises a nucleic acid sequence encoding at least one subunit of a heterologous heteromultimeric protein, which coding sequence is operably linked to a promoter and a signal sequence that directs the secretion of said subunit by a Pichia yeast;

(ii) obtaining a second haploid Pichia yeast which comprises a nucleic acid sequence encoding at least one subunit of the same heterologous heteromultimeric protein, wherein the subunits encoded by the first and second haploid Pichia yeast strains comprise all of the subunits of the desired heterologous heteromultimeric protein, and which coding sequence is operably linked to a promoter and a signal sequence that directs the secretion of said subunit by a Pichia yeast;

(iii) fusing said first and second haploid Pichia yeast strains by spheroplast fusion or by mating to produce a diploid Pichia yeast strain which is capable of expression and secretion of the desired heterologous heteromultimeric protein into a culture medium, wherein said first and second haploid Pichia yeast strains are of the same species;

(iv) culturing the resultant diploid Pichia yeast strain under culture conditions wherein at least about 50 mg/L of said heterologous heteromultimeric protein is secreted into the culture medium during said culture period; and

(v) recovering the secreted heterologous heteromultimeric protein from the culture medium.

2. The method of claim 1 , wherein the diploid Pichia yeast strain is produced by mating.

3. The method of claim 1 , wherein the diploid Pichia yeast strain is produced by spheroplast fusion.

4. The method according to claim 1 , wherein both said first and second haploid Pichia yeast strains are Pichia pastoris, Pichia methanolica, or Pichia angusta.

5. The method according to claim 2 , wherein both said first and second haploid Pichia yeast strains are Pichia pastoris, Pichia methanolica, or Pichia angusta.

6. The method according to claim 3 , wherein both said first and second haploid Pichia yeast strains are Pichia pastoris, Pichia methanolica, or Pichia angusta.

7. The method according to claim 1 , wherein said heterologous heteromultimeric protein is a mammalian protein.

8. The method according to claim 1 , wherein said heterologous heteromultimeric protein is an intact antibody comprising heavy and light variable regions and human constant regions.

9. The method according to claim 1 , wherein said heterologous heteromultimeric protein is a human polypeptide.

10. The method according to claim 1 , wherein both said first and said second haploid Pichia yeast strains are auxotrophic.

11. The method according to claim 1 , wherein in steps (i) and (ii) the nucleic acid sequences encoding the subunits are respectively operably linked to a first promoter and a second promoter which first and second promoters are the same or different.

12. The method according to claim 11 , wherein said first and second promoters are both inducible promoters.

13. The method according to claim 11 , wherein at least one of said first and second promoters is a GAP promoter.

14. The method of claim 1 , wherein both said first and said second haploid Pichia yeast strains are Pichia pastoris strains.

15. The method of claim 2 , wherein both said first and said second haploid Pichia yeast strains are Pichia pastoris strains.

16. The method of claim 3 , wherein both said first and said second haploid Pichia yeast strains are Pichia pastoris strains.

17. The method of claim 8 , wherein both said first and said second haploid Pichia yeast strains are Pichia pastoris strains.

18. The method of claim 9 , wherein both said first and said second haploid Pichia yeast strains are Pichia pastoris strains.

19. The method of claim 1 , wherein the culture period comprises culturing the diploid Pichia cells for at least 20 doublings and after said at least 20 doublings continue to express said heterologous heteromultimeric protein.

20. The method of claim 19 , wherein the culture period comprises culturing the diploid Pichia cells for at least 50 doublings and after said at least 50 doublings continue to express said heterologous heteromultimeric protein.

21. The method of claim 19 , wherein the culture period comprises culturing the diploid Pichia cells for at least 100 doublings and after said at least 100 doublings continue to express said heterologous heteromultimeric protein.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 054161 FRAME: 0877. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 2, 2021
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S
Reel/Frame 056449/0543 →
CHANGE OF NAME Recorded Sep 3, 2020
From: ALDER BIOPHARMACEUTICALS, INC
To: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
Reel/Frame 053681/0224 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2020
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S.
Reel/Frame 054161/0877 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2020
From: ALDERBIO HOLDINGS LLC
To: H. LUNDBECK A/S
Reel/Frame 053020/0331 →
Continuity (5)
Division 13598885 · Aug 30, 2012
Division 10577074
Provisional Application 60513876 · Oct 22, 2003
Related Publication 20140206039A1 · Jul 24, 2014
Related Publication 20160297887A9 · Oct 13, 2016